SCHEDULE 13G/A: Morgan Stanley Discloses 5.9% Stake in U.S. Physical Therapy; Calvert Entities Reduce Holdings Below 5%
Beneficial Ownership Disclosure
Morgan Stanley and its affiliates, including Calvert Research and Management and Calvert Impact Fund, Inc. Calvert Small-Cap Fund, have filed an amended Schedule 13G disclosing their beneficial ownership in U.S. Physical Therapy Inc., with Morgan Stanley holding 5.9% while the Calvert entities have reduced their stakes below the 5% threshold.
Summary
- Morgan Stanley, as a parent holding company, beneficially owns 889,644 shares of U.S. Physical Therapy Inc. common stock, representing 5.9% of the class.
- Calvert Research and Management, an investment adviser and wholly-owned subsidiary of Morgan Stanley, beneficially owns 635,280 shares, representing 4.2% of the class.
- Calvert Impact Fund, Inc. Calvert Small-Cap Fund, also an investment adviser, beneficially owns 590,428 shares, representing 3.9% of the class.
- Both Calvert Research and Management and Calvert Impact Fund, Inc. Calvert Small-Cap Fund have ceased to be beneficial owners of more than five percent of the class of securities as of the filing date.
Sentiment
Score: 4
Explanation: The sentiment is slightly negative due to the reduction in beneficial ownership by the Calvert entities below the 5% threshold, despite Morgan Stanley maintaining a significant stake.
Positives
- Morgan Stanley maintains a significant beneficial ownership stake of 5.9% in U.S. Physical Therapy Inc., indicating continued institutional interest.
Negatives
- Calvert Research and Management has reduced its beneficial ownership to 4.2%, falling below the 5% reporting threshold.
- Calvert Impact Fund, Inc. Calvert Small-Cap Fund has reduced its beneficial ownership to 3.9%, also falling below the 5% reporting threshold.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency on significant institutional ownership and changes in passive stakes, which may influence investor perception and trading decisions.
Key Dates
| Date | Description |
|---|---|
| 12/31/2024 | Date of event requiring the filing of this statement. |
| 02/05/2025 | Date of filing of this Schedule 13G Amendment No. 2. |
Keywords
U.S. Physical Therapy, USPH, Morgan Stanley, Calvert Research and Management, Calvert Impact Fund, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, SEC Filing, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.